Cargando…
Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity
BACKGROUND: Conventional chemotherapy in malignant pleural mesothelioma (MPM) has minimal impact on patient survival due to the supposed chemoresistance of cancer stem cells (CSCs). We sought to identify a sub-population of chemoresistant cells by using putative CSC markers, aldehyde dehydrogenase (...
Autores principales: | Cortes-Dericks, Lourdes, Froment, Laurene, Boesch, Ruben, Schmid, Ralph Alexander, Karoubi, Golnaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021184/ https://www.ncbi.nlm.nih.gov/pubmed/24884875 http://dx.doi.org/10.1186/1471-2407-14-304 |
Ejemplares similares
-
Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines
por: Cortes-Dericks, Lourdes, et al.
Publicado: (2016) -
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives
por: Cortes-Dericks, Lourdes, et al.
Publicado: (2017) -
Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma
por: Borchert, Sabrina, et al.
Publicado: (2020) -
Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma
por: Goudar, Ranjit K
Publicado: (2008) -
Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight
por: Cortes-Dericks, Lourdes, et al.
Publicado: (2022)